uPAR Is Highly Expressed in Recurrent Glioblastoma and Represents a Candidate CAR T Cell Target

Scientists generated urokinase plasminogen activator receptor (uPAR)-specific CAR T cells, which demonstrated potent antitumor activity in recurrent glioblastoma patient–derived xenograft models.